PECAM1 and neoplasm: Moreover, PPIX at the dose of 0.3 or 1.0 mg/kg suppressed the induction of E2F3, Ki-67, and CD31 in the xenograft tumors (Figure 6D), verifying the ability of PPIX to inhibit tumor cell proliferation and angiogenesis.